focus -WSS

focus

author：Wikipedia 2025-10-01 11:02:06 - browse：8737

ASH19 CAR-T — Victor Segura Ibarra and Rita Serda, Ph.D., NCI, NIH

The Food and Drug Administration on Wednesday approved a futuristic new approach to treating cancer, clearing a Novartis therapy that has produced unprecedented results in patients with a rare and deadly cancer. The price tag: $475,000 for a course of treatment.

That sounds staggering to many patients — but it’s far less than analysts expected.

The therapy, called a CAR-T, is made by harvesting patients’ white blood cells and rewiring them to home in on tumors. Novartis’s product is the first CAR-T therapy to come before the FDA, leading a pack of novel treatments that promise to change the standard of care for certain aggressive blood cancers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： The drug industry has found itself all alone in Washington

hotspot

WSS

Just how do doctors, lawmakers, and the public define abortion?

Amylyx ALS drug failure raises questions and concerns

Change Healthcare payments predicted restored March 15

Readout LOUD podcast: Live from STAT Breakthrough Summit West

Analysis of pharma R&D ranks Novo Nordisk, J&J above their peers

It's time to retire 'poor historian' from clinicians' vocabularies

focus

focus

hotspot

Trump demands the U.S. pay no more for drugs than other countries … again

Case highlights the risks of experimental stem cell therapy

Activists slam private health insurers over coverage restrictions

Readers respond to H5N1 and livestock movements, and more

State Dept. review finds Biden bears some blame for Afghanistan failures

It's time to retire 'poor historian' from clinicians' vocabularies

The high cost of giving birth even with insurance

Readers respond to H5N1 and livestock movements, and more

Continuity nursing helped my family in our darkest PICU moments

How a billionaire couple greased the skids for Pelosi’s drug pricing bill

entertainment

Arc Institute generative AI designs new CRISPR systems

Readout LOUD podcast: Live from STAT Breakthrough Summit West

Arc Institute generative AI designs new CRISPR systems

How a billionaire couple greased the skids for Pelosi’s drug pricing bill

When prostate cancer spreads, where it goes matters

Former medical device CEO who sold dummy, plastic parts convicted of fraud

hotspot

entertainment

focus

hotspot